Overview

Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients

Status:
Recruiting
Trial end date:
2025-04-30
Target enrollment:
Participant gender:
Summary
The objective of this randomized, controlled pilot study is to determine the efficacy of Deferiprone to reduce the amount of free unbound iron inside the hemorrhagic zone of myocardial infarction among hemorrhagic myocardial infarction patients.
Phase:
Phase 1
Details
Lead Sponsor:
Rohan Dharmakumar
Collaborators:
Cardio-theranostics LLC
Lipomed AG
Treatments:
Deferiprone